This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

The burden of CMV in adult allogeneic HSCT recipients

Prescribing Information

Length: 04:21

Professor Karl Peggs, Consultant Haematologist, University College London Hospitals NHS Foundation Trust

Hear Professor Peggs discuss the impact of cytomegalovirus (CMV) in adult patients undergoing allogeneic haematopoietic stem cell transplants. The prevalence of CMV reactivation, effect of viral load on survival outcomes and the unmet need of controlling CMV infection in this population are all discussed.

Supporting documentation

GB-CYT-00070 | Date of Preparation: May 2019